Morning Briefing
Summaries of health policy coverage from major news organizations
Media Outlets Examine How AIDS Vaccine Trial Results Will Shape Future Studies
As the AIDS vaccine conference continues in Paris this week, Reuters examines how recent trials are helping researchers better understand ways to develop a vaccine that offers people protection from HIV. Researchers involved in Merck's AIDS vaccine trial, which was halted in 2007 after it was feared the vaccine raised study participants' risk of infection, presented follow-up data from the trial during the conference on Tuesday.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
